Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia

American Journal of Medical Genetics
J L Van HoveS G Kahler

Abstract

Five patients presenting with non-ketotic hyperglycinemia in the neonatal period were treated with sodium benzoate to normalize plasma glycine levels. This therapy resulted in seizure reduction and a marked increase in wakefulness. Plasma carnitine deficiency was noted in three of four patients tested, and benzoylcarnitine was identified in plasma, urine, and CSF. Treatment with L-carnitine normalized plasma free carnitine. L-carnitine showed a tendency to increase the glycine conjugation of benzoate. An episode of coma and increased seizures in one patient was associated with a toxic level of benzoate, probably due to insufficient mobilization of glycine for conjugation. High dose benzoate therapy improved the quality of life of surviving patients. Close monitoring of glycine, benzoate and carnitine levels is advised.

References

Jun 12, 1975·The New England Journal of Medicine·T L PerryJ E Lock
Jul 15, 1991·Biochemical Pharmacology·D M CyrG C Tremblay
Jan 1, 1991·European Journal of Clinical Pharmacology·K Kubota, T Ishizaki
Jan 1, 1991·Developmental Pharmacology and Therapeutics·G M PacificiA Rane
Jul 1, 1991·Archives of Disease in Childhood·T Sakuma
Jan 1, 1991·Virchows Archiv. A, Pathological Anatomy and Histopathology·J Thiele, R Fischer
May 1, 1991·Pediatric Neurology·E MayatepekW T Gunning
Aug 1, 1991·Biochemical Medicine and Metabolic Biology·A G Palekar, S S Kalbag
Oct 1, 1990·Journal of Pediatric Gastroenterology and Nutrition·K A DahlströmG Cederblad
Nov 26, 1990·European Journal of Biochemistry·D LangoschH Betz
Jan 31, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·N KodoC R Roe
Sep 1, 1989·Trends in Neurosciences·A M Thomson
Feb 15, 1989·Archives of Biochemistry and Biophysics·A D GriffithG C Tremblay
Oct 1, 1989·The Tohoku Journal of Experimental Medicine·T SakumaY Wada
Jun 1, 1989·The Journal of Pediatrics·A S LuderC L Greene
Jan 1, 1988·Developmental Pharmacology and Therapeutics·M LeBelC Carrier
Jan 1, 1987·Enzyme·M L Batshaw, P S Monahan
Jun 15, 1987·Biochemical and Biophysical Research Communications·J E O'ConnorS Grisolía
Oct 1, 1986·Biochemical Medicine and Metabolic Biology·C BachmannJ P Colombo
Dec 1, 1969·The Journal of Pediatrics·R BaumgartnerW L Nyhan
Jun 21, 1984·The New England Journal of Medicine·S W BrusilowJ Ward
Dec 1, 1984·The Journal of Clinical Investigation·C R RoeT P Bohan
May 1, 1983·The Journal of Pediatrics·T P GreenD K Freese
Jun 6, 1980·Biochimica Et Biophysica Acta·J BenavidesF Valdivieso
Jan 1, 1993·Journal of Inherited Metabolic Disease·K Tada, S Kure
Jul 1, 1961·Journal of Applied Physiology·A D RENZETTIJ F BOWEN

❮ Previous
Next ❯

Citations

Jan 5, 2008·Indian Journal of Pediatrics·Rahul P Bhamkar, Prisca Colaco
Sep 6, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jörg BreitkreutzPeter Kleinebudde
Apr 12, 2001·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·L GabisW Huang
Sep 10, 2005·Journal of Inherited Metabolic Disease·J L K Van HoveJ Jaeken
Oct 18, 2011·Journal of Inherited Metabolic Disease·Julia B HennermannJohan L K Van Hove
May 27, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C EckertJ Breitkreutz
Aug 28, 2012·La Presse médicale·Sana AbourazzakMoustapha Hida
Sep 21, 2010·Paediatric Anaesthesia·David A August, Hung G Nguyen
Jul 17, 2015·Annals of Neurology·Michael A SwansonJohan L K Van Hove
Nov 29, 2005·Metabolism: Clinical and Experimental·Balazs DebreceniAttila Sandor
Jun 6, 2000·Biochimica Et Biophysica Acta·G M FischerA Sandor
Nov 12, 2002·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J H Osorio, M Pourfarzam
May 9, 2000·Journal of Inherited Metabolic Disease·S CataltepeH L Levy
Feb 22, 2000·Journal of Inherited Metabolic Disease·E J WiltshireJ M Fletcher
Apr 2, 2021·Metabolic Brain Disease·Harun BayrakMustafa Kılıç
Jun 1, 1997·The Journal of Pediatrics·Y MawalI A Qureshi
Mar 11, 2008·Metabolism: Clinical and Experimental·Laura M TannerOlli Simell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.